Mathias G. Lichtenheld - Publications

University of Miami, Coral Gables, FL 
Immunology, Molecular Biology

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 McCormack RM, de Armas LR, Shiratsuchi M, Fiorentino DG, Olsson ML, Lichtenheld MG, Morales A, Lyapichev K, Gonzalez LE, Strbo N, Sukumar N, Stojadinovic O, Plano GV, Munson GP, Tomic-Canic M, et al. Perforin-2 is essential for intracellular defense of parenchymal cells and phagocytes against pathogenic bacteria. Elife. 4. PMID 26402460 DOI: 10.7554/Elife.06508  0.4
2013 Lee JH, Wittki S, Bräu T, Dreyer FS, Krätzel K, Dindorf J, Johnston IC, Gross S, Kremmer E, Zeidler R, Schlötzer-Schrehardt U, Lichtenheld M, Saksela K, Harrer T, Schuler G, et al. HIV Nef, paxillin, and Pak1/2 regulate activation and secretion of TACE/ADAM10 proteases. Molecular Cell. 49: 668-79. PMID 23317503 DOI: 10.1016/J.Molcel.2012.12.004  0.4
2011 Parmigiani A, Pallin MF, Schmidtmayerova H, Lichtenheld MG, Pahwa S. Interleukin-21 and cellular activation concurrently induce potent cytotoxic function and promote antiviral activity in human CD8 T cells. Human Immunology. 72: 115-23. PMID 20977918 DOI: 10.1016/J.Humimm.2010.10.015  0.4
2010 Pipkin ME, Rao A, Lichtenheld MG. The transcriptional control of the perforin locus. Immunological Reviews. 235: 55-72. PMID 20536555 DOI: 10.1111/J.0105-2896.2010.00905.X  0.92
2010 Pipkin ME, Sacks JA, Cruz-Guilloty F, Lichtenheld MG, Bevan MJ, Rao A. Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. Immunity. 32: 79-90. PMID 20096607 DOI: 10.1016/J.Immuni.2009.11.012  0.4
2009 Cruz-Guilloty F, Pipkin ME, Djuretic IM, Levanon D, Lotem J, Lichtenheld MG, Groner Y, Rao A. Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs. The Journal of Experimental Medicine. 206: 51-9. PMID 19139168 DOI: 10.1084/Jem.20081242  0.4
2008 Strbo N, de Armas L, Liu H, Kolber MA, Lichtenheld M, Pahwa S. IL-21 augments natural killer effector functions in chronically HIV-infected individuals. Aids (London, England). 22: 1551-60. PMID 18670213 DOI: 10.1097/Qad.0B013E3283089367  0.4
2007 Rose S, Lichtenheld M, Foote MR, Adkins B. Murine neonatal CD4+ cells are poised for rapid Th2 effector-like function. Journal of Immunology (Baltimore, Md. : 1950). 178: 2667-78. PMID 17312108 DOI: 10.4049/Jimmunol.178.5.2667  0.4
2007 Pipkin ME, Ljutic B, Cruz-Guilloty F, Nouzova M, Rao A, Zúñiga-Pflücker JC, Lichtenheld MG. Chromosome transfer activates and delineates a locus control region for perforin. Immunity. 26: 29-41. PMID 17222571 DOI: 10.1016/J.Immuni.2006.11.009  0.4
2007 White L, Krishnan S, Strbo N, Liu H, Kolber MA, Lichtenheld MG, Pahwa RN, Pahwa S. Differential effects of IL-21 and IL-15 on perforin expression, lysosomal degranulation, and proliferation in CD8 T cells of patients with human immunodeficiency virus-1 (HIV). Blood. 109: 3873-80. PMID 17192392 DOI: 10.1182/Blood-2006-09-045278  0.4
2006 Pipkin ME, Lichtenheld MG. A reliable method to display authentic DNase I hypersensitive sites at long-ranges in single-copy genes from large genomes. Nucleic Acids Research. 34: e34. PMID 16510851 DOI: 10.1093/Nar/Gkl006  0.92
2005 Buzzeo R, Enkemann S, Nimmanapalli R, Alsina M, Lichtenheld MG, Dalton WS, Beaupre DM. Characterization of a R115777-resistant human multiple myeloma cell line with cross-resistance to PS-341. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 6057-64. PMID 16115951 DOI: 10.1182/Blood.V104.11.3363.3363  0.4
2005 Zhu K, Gerbino E, Beaupre DM, Mackley PA, Muro-Cacho C, Beam C, Hamilton AD, Lichtenheld MG, Kerr WG, Dalton W, Alsina M, Sebti SM. Farnesyltransferase inhibitor R115777 (Zarnestra, Tipifarnib) synergizes with paclitaxel to induce apoptosis and mitotic arrest and to inhibit tumor growth of multiple myeloma cells. Blood. 105: 4759-66. PMID 15728126 DOI: 10.1182/Blood-2004-11-4307  0.4
1999 Zhang J, Scordi I, Smyth MJ, Lichtenheld MG. Interleukin 2 receptor signaling regulates the perforin gene through signal transducer and activator of transcription (Stat)5 activation of two enhancers Journal of Experimental Medicine. 190: 1297-1307. PMID 10544201 DOI: 10.1084/Jem.190.9.1297  0.4
1989 Lowrey DM, Aebischer T, Olsen K, Lichtenheld M, Rupp F, Hengartner H, Podack ER. Cloning, analysis, and expression of murine perforin 1 cDNA, a component of cytolytic T-cell granules with homology to complement component C9. Proceedings of the National Academy of Sciences of the United States of America. 86: 247-51. PMID 2783486 DOI: 10.1073/Pnas.86.1.247  0.4
1989 Podack ER, Olsen KJ, Lowrey DM, Lichtenheld M. Structure and function of perforin Current Topics in Microbiology and Immunology. 140: 11-17. PMID 2644072 DOI: 10.1007/978-3-642-73911-8_2  0.4
1989 Hameed A, Olsen KJ, Lee MK, Lichtenheld MG, Podack ER. Cytolysis by Ca-permeable transmembrane channels. Pore formation causes extensive DNA degradation and cell lysis Journal of Experimental Medicine. 169: 765-777. PMID 2538546 DOI: 10.1084/Jem.169.3.765  0.4
1988 Lichtenheld MG, Olsen KJ, Lu P, Lowrey DM, Hameed A, Hengartner H, Podack ER. Structure and function of human perforin Nature. 335: 448-451. PMID 3419519 DOI: 10.1038/335448A0  0.4
1988 Podack ER, Lowrey DM, Lichtenheld M, Olsen KJ, Aebischer T, Binder D, Rupp F, Hengartner H. Structure, function and expression of murine and human perforin 1 (P1). Immunological Reviews. 103: 203-11. PMID 3292394 DOI: 10.1111/J.1600-065X.1988.Tb00756.X  0.4
Show low-probability matches.